Your session is about to expire
← Back to Search
Nasal saline irrigation for Pituitary Tumors (NOSE Trial)
NOSE Trial Summary
This is a prospective, single-blinded, multicenter study evaluating the benefit of sinonasal irrigations following endoscopic pituitary surgery. The goal of this study is to create practice changing guidelines with objective data highlighting the importance of irrigations on postoperative outcomes for pituitary surgery.
- Pituitary Tumors
NOSE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNOSE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NOSE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this trial include individuals aged 35 and above?
"According to the enrolment criteria, participants must be between 19 and 85 years of age. Separate research designs exist for those under 18 or over 65."
Is recruitment for this experiment open at the present time?
"According to the clinicaltrials.gov website, this scientific experiment is actively recruiting patients; its inception was on December 18th 2020 and there has been recent activity as of December 19th 2022."
What is the current enrollment capacity of this trial?
"Affirmative. The information found on clinicaltrials.gov confirms that, as of the most recent update from December 19th 2022, this medical study is actively searching for participants across two sites with a total goal of 140 patients recruited."
Are there specific demographics that are particularly suited for this research endeavor?
"This clinical trial needs 140 participants between the ages of 19 and 85 that are afflicted with pituitary adenoma. In order to meet all criteria for enrollment, potential patients must be adults above 18 years old, able to comprehend English and take two scales (ASK Nasal-12 & SNOT-22), free from any physical or mental health issues deemed a detriment by investigators, opt for binostril surgical approach with/without septal flap reconstruction."
Share this study with friends
Copy Link
Messenger